Loading...

BIO-UV Group

ENXTPA:ALTUV
Snowflake Description

High growth potential with mediocre balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
ALTUV
ENXTPA
€30M
Market Cap
  1. Home
  2. FR
  3. Capital Goods
Company description

BIO-UV Group S.A. manufactures and markets ultraviolet light water treatment equipment for individuals and professionals in France. The last earnings update was 49 days ago. More info.


Add to Portfolio Compare Print
ALTUV Share Price and Events
7 Day Returns
0%
ENXTPA:ALTUV
-0.7%
FR Machinery
-0%
FR Market
1 Year Returns
-
ENXTPA:ALTUV
-5.7%
FR Machinery
-1.2%
FR Market
ALTUV Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
BIO-UV Group (ALTUV) 0% 6.1% 6.6% - - -
FR Machinery -0.7% 4.5% 3.9% -5.7% 61.8% 30.6%
FR Market -0% -0.9% -0.3% -1.2% 30.8% 28.6%
1 Year Return vs Industry and Market
  • No trading data on ALTUV.
  • No trading data on ALTUV.
Price Volatility
Industry
5yr Volatility vs Market

Value

 Is BIO-UV Group undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of BIO-UV Group to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for BIO-UV Group.

ENXTPA:ALTUV Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 1 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 8.4%
Perpetual Growth Rate 10-Year FR Government Bond Rate 0.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for ENXTPA:ALTUV
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year FR Govt Bond Rate 0.7%
Equity Risk Premium S&P Global 6.7%
Machinery Unlevered Beta Simply Wall St/ S&P Global 1.06
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.061 (1 + (1- 33%) (22.04%))
1.146
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.15
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.73% + (1.146 * 6.65%)
8.36%

Discounted Cash Flow Calculation for ENXTPA:ALTUV using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for BIO-UV Group is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

ENXTPA:ALTUV DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (EUR, Millions) Source Present Value
Discounted (@ 8.36%)
2019 -1.50 Analyst x1 -1.38
2020 -2.80 Analyst x1 -2.38
2021 0.40 Analyst x1 0.31
2022 0.56 Est @ 39.17% 0.40
2023 0.71 Est @ 27.64% 0.48
2024 0.85 Est @ 19.57% 0.52
2025 0.97 Est @ 13.92% 0.55
2026 1.06 Est @ 9.96% 0.56
2027 1.14 Est @ 7.19% 0.55
2028 1.20 Est @ 5.26% 0.54
Present value of next 10 years cash flows €0.15
ENXTPA:ALTUV DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= €1.20 × (1 + 0.73%) ÷ (8.36% – 0.73%)
€15.87
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= €15.87 ÷ (1 + 8.36%)10
€7.11
ENXTPA:ALTUV Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= €0.15 + €7.11
€7.27
Equity Value per Share
(EUR)
= Total value / Shares Outstanding
= €7.27 / 7.84
€0.93
ENXTPA:ALTUV Discount to Share Price
Calculation Result
Value per share (EUR) From above. €0.93
Current discount Discount to share price of €3.85
= -1 x (€3.85 - €0.93) / €0.93
-315.2%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of BIO-UV Group is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for BIO-UV Group's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are BIO-UV Group's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
ENXTPA:ALTUV PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in EUR €0.01
ENXTPA:ALTUV Share Price ** ENXTPA (2019-06-18) in EUR €3.85
France Machinery Industry PE Ratio Median Figure of 12 Publicly-Listed Machinery Companies 12.14x
France Market PE Ratio Median Figure of 423 Publicly-Listed Companies 17.59x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of BIO-UV Group.

ENXTPA:ALTUV PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ENXTPA:ALTUV Share Price ÷ EPS (both in EUR)

= 3.85 ÷ 0.01

651.66x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • BIO-UV Group is overvalued based on earnings compared to the FR Machinery industry average.
  • BIO-UV Group is overvalued based on earnings compared to the France market.
Price based on expected Growth
Does BIO-UV Group's expected growth come at a high price?
Raw Data
ENXTPA:ALTUV PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 651.66x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
88.6%per year
France Machinery Industry PEG Ratio Median Figure of 5 Publicly-Listed Machinery Companies 1.23x
France Market PEG Ratio Median Figure of 268 Publicly-Listed Companies 1.51x

*Line of best fit is calculated by linear regression .

ENXTPA:ALTUV PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 651.66x ÷ 88.6%

7.35x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • BIO-UV Group is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on BIO-UV Group's assets?
Raw Data
ENXTPA:ALTUV PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in EUR €2.14
ENXTPA:ALTUV Share Price * ENXTPA (2019-06-18) in EUR €3.85
France Machinery Industry PB Ratio Median Figure of 21 Publicly-Listed Machinery Companies 1.32x
France Market PB Ratio Median Figure of 623 Publicly-Listed Companies 1.45x
ENXTPA:ALTUV PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ENXTPA:ALTUV Share Price ÷ Book Value per Share (both in EUR)

= 3.85 ÷ 2.14

1.8x

* Primary Listing of BIO-UV Group.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • BIO-UV Group is overvalued based on assets compared to the FR Machinery industry average.
X
Value checks
We assess BIO-UV Group's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Machinery industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Machinery industry average (and greater than 0)? (1 check)
  5. BIO-UV Group has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is BIO-UV Group expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
88.6%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is BIO-UV Group expected to grow at an attractive rate?
  • BIO-UV Group's earnings growth is expected to exceed the low risk savings rate of 0.7%.
Growth vs Market Checks
  • BIO-UV Group's earnings growth is expected to exceed the France market average.
  • BIO-UV Group's revenue growth is expected to exceed the France market average.
Annual Growth Rates Comparison
Raw Data
ENXTPA:ALTUV Future Growth Rates Data Sources
Data Point Source Value (per year)
ENXTPA:ALTUV Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts 88.6%
ENXTPA:ALTUV Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 27.8%
France Machinery Industry Earnings Growth Rate Market Cap Weighted Average 14.3%
France Machinery Industry Revenue Growth Rate Market Cap Weighted Average 6.1%
France Market Earnings Growth Rate Market Cap Weighted Average 12.8%
France Market Revenue Growth Rate Market Cap Weighted Average 4.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
ENXTPA:ALTUV Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
ENXTPA:ALTUV Future Estimates Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-12-31 42 1
2021-12-31 35 4 2 1
2020-12-31 29 3 1 1
2019-12-31 17 2 0 1
ENXTPA:ALTUV Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2018-12-31 13 -2 0
2017-12-31 11 2 0
2016-12-31 11 -1 2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • BIO-UV Group's earnings are expected to grow significantly at over 20% yearly.
  • BIO-UV Group's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
ENXTPA:ALTUV Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from BIO-UV Group Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ENXTPA:ALTUV Future Estimates Data
Date (Data in EUR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-12-31
2021-12-31 0.28 0.28 0.28 1.00
2020-12-31 0.15 0.15 0.15 1.00
2019-12-31 -0.01 -0.01 -0.01 1.00
ENXTPA:ALTUV Past Financials Data
Date (Data in EUR Millions) EPS *
2018-12-31 0.01
2017-12-31 -0.02
2016-12-31 0.40

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • BIO-UV Group is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess BIO-UV Group's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the France market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the France market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
BIO-UV Group has a total score of 5/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has BIO-UV Group performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare BIO-UV Group's growth in the last year to its industry (Machinery).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Insufficient data to establish if BIO-UV Group's year on year earnings growth rate was positive over the past 5 years.
  • BIO-UV Group has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.
  • BIO-UV Group has become profitable in the last year making it difficult to compare the FR Machinery industry average.
Earnings and Revenue History
BIO-UV Group's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from BIO-UV Group Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ENXTPA:ALTUV Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 13.10 0.05 3.73
2017-12-31 10.54 -0.09 3.27
2016-12-31 11.45 1.62 3.10

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • BIO-UV Group has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • BIO-UV Group used its assets less efficiently than the FR Machinery industry average last year based on Return on Assets.
  • Unable to establish if BIO-UV Group improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to insufficient past data.
X
Past performance checks
We assess BIO-UV Group's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Machinery industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
BIO-UV Group has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is BIO-UV Group's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up BIO-UV Group's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • BIO-UV Group is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • BIO-UV Group's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of BIO-UV Group's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 2.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from BIO-UV Group Company Filings, last reported 5 months ago.

ENXTPA:ALTUV Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 16.76 6.65 5.92
2017-12-31 6.00 8.42 1.01
2016-12-31 6.14 7.81 2.17
  • BIO-UV Group's level of debt (39.7%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if BIO-UV Group's debt level has increased without past 5-year debt data.
  • Operating cash flow is negative therefore debt is not well covered.
  • Interest payments on debt are not well covered by earnings (EBIT is 0.1x annual interest expense, ideally 3x coverage).
X
Financial health checks
We assess BIO-UV Group's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. BIO-UV Group has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is BIO-UV Group's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from BIO-UV Group dividends. Estimated to be 0% next year.
If you bought €2,000 of BIO-UV Group shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate BIO-UV Group's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate BIO-UV Group's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
ENXTPA:ALTUV Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
France Machinery Industry Average Dividend Yield Market Cap Weighted Average of 11 Stocks 11.1%
France Market Average Dividend Yield Market Cap Weighted Average of 322 Stocks 3.1%
France Minimum Threshold Dividend Yield 10th Percentile 1%
France Bottom 25% Dividend Yield 25th Percentile 1.5%
France Top 25% Dividend Yield 75th Percentile 4.4%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

ENXTPA:ALTUV Future Dividends Estimate Data
Date (Data in €) Dividend per Share (annual) Avg. No. Analysts
2022-12-31
2021-12-31 0.00 1.00
2020-12-31 0.00 1.00
2019-12-31 0.00 1.00

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as BIO-UV Group has not reported any payouts.
  • Unable to verify if BIO-UV Group's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of BIO-UV Group's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as BIO-UV Group has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of BIO-UV Group's dividends in 3 years as they are not expected to pay a notable one for France.
X
Income/ dividend checks
We assess BIO-UV Group's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can BIO-UV Group afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. BIO-UV Group has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of BIO-UV Group's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
  • BIO-UV Group has no CEO, or we have no data on them.
Management Team

Benoit Gillmann

TITLE
MD & Chairman
Board of Directors

Eric Bellet

TITLE
Director

Yves Fonderflick

TITLE
Director
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess BIO-UV Group's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. BIO-UV Group has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Can We See Significant Insider Ownership On The BIO-UV Group S.A. (EPA:ALTUV) Share Register?

Insider Ownership Of BIO-UV Group While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. … Private Company Ownership We can see that Private Companies own 9.2%, of the shares on issue. … Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

Simply Wall St -

Is BIO-UV Group S.A.'s (EPA:ALTUV) Balance Sheet Strong Enough To Weather A Storm?

Want to participate in a short research study? … Help shape the future of investing tools and you could win a $250 gift card! … (EPA:ALTUV) with its market cap of €29m, are popular for their explosive growth, investors should also be aware of their balance sheet to judge whether the company can survive a downturn.

Simply Wall St -

Do Insiders Own Shares In BIO-UV Group S.A. (EPA:ALTUV)?

(EPA:ALTUV), then you'll have to look at the makeup of its share registry. … I generally like to see some degree of insider ownership, even if only a little. … Taking a look at the our data on the ownership groups (below), it's seems that.

Simply Wall St -

What You Must Know About BIO-UV Group S.A.'s (EPA:ALTUV) Financial Strength

(EPA:ALTUV) with its market cap of €23m, are popular for their explosive growth, investors should also be aware of their balance sheet to judge whether the company can survive a downturn.

Simply Wall St -

Do Insiders Own Shares In BIO-UV Group SA (EPA:ALTUV)?

Generally speaking, as a company grows, institutions will increase their ownership. … BIO-UV Group is not a large company by global standards. … See our latest analysis for BIO-UV Group

Simply Wall St -

How Financially Strong Is BIO-UV Group SA (EPA:ALTUV)?

BIO-UV Group SA (EPA:ALTUV) is a small-cap stock with a market capitalization of €30.4m. … While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health.

Simply Wall St -

Company Info

Description

BIO-UV Group S.A. manufactures and markets ultraviolet light water treatment equipment for individuals and professionals in France. Its products are used in various applications, including automatic water treatment with or without chlorine for private swimming pools and spas; disinfection and/or dechloramination in collective swimming pools and spas; purification of fresh or salt water in aquaculture and aquariums; domestic and urban water purification; production of drinking water in isolated areas using photovoltaic energy; treatment of waste water reused; disinfection of water from industrial processes and ultra-pure water; treatment of legionella; treatment of ballast water; and others. The company was founded in 2000 and is based in Lunel, France.

Details
Name: BIO-UV Group S.A.
ALTUV
Exchange: ENXTPA
Founded: 2000
€30,176,180
7,837,969
Website: http://www.bio-uv.com
Address: BIO-UV Group S.A.
850 avenue Louis Medard,
Lunel,
Languedoc-Roussillon, 34400,
France
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ENXTPA ALTUV Common Shares Euronext Paris FR EUR 10. Jul 2018
Number of employees
Current staff
Staff numbers
64
BIO-UV Group employees.
Industry
Industrial Machinery
Capital Goods
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/06/18 22:29
End of day share price update: 2019/06/18 00:00
Last estimates confirmation: 2019/05/27
Last earnings filing: 2019/04/30
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.